Highlighting our very own Dr. Ivan Pedrosa @UTSWNews UTSW Radiology KidneyCancerProgram discussing role of AI for localized #KidneyCancer Tian Zhang, MD, MHS #IKCSNA23

The FDA has approved belzutifan for the treatment of advanced renal cell carcinoma- a first-in-class drug discovered and developed by UTSW researchers over three decades. bit.ly/BelzutifanAppr… @UTSWNews UTSW Simmons Cancer Center UTSW Internal Medicine

Reaching your destination can require a diversion nature.com/articles/s4301… A chance encounter changed the trajectory of my career, as I was all set to be a full time pathologist. Thanks to Lisa Hoffmann-Haas Nature Cancer for this opportunity. Share your career turning point(s). ↪️

📢Publication alert! 📢 #UTSWKCP researchers, supported by Joey's Wings Foundation, CPRIT, Dallas DASH, the Plano Pacers, and countless patient contributions, have developed a faithful mouse model of tRCC. Via the JCI🔗: bit.ly/tRCCModel

Lifetime Achievement Award GU Pathology Society (GUPS) to our MSK Department of Pathology & Laboratory Medicine colleague and leader, Dr Victor Reuter for his myriad contributions to advancing #gupath #USCAP2024

Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis: buff.ly/3xvn972 James Brugarolas Payal Kapur UTSW Simmons Cancer Center #CellBiology #Oncology

Congrats. Very nicely done.

Check out this preprint by Rebecca Collins et al. Pediatric Pathology at UT Southwestern UTSW Department of Pathology describing the role of MAGEs in #medulloblastoma Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors biorxiv.org/content/10.110…

#PediPath

Congratulations to Payal Kapur Genentech Dinesh Rakheja KidneyCancerProgram and all on jci.me/176743/pdf reporting mechanism of transformation of #chRCC #sarcomatoid

Congratulations to Gerta Hoxhaj Lab and coauthors DeBerardinis Lab Hao Zhu Lab et al. on Cell #cancermetabolism paper seeded with National Cancer Institute #RCC #SPORE KidneyCancerProgram CEP award

…..and congratulations to her hugely accomplished mother Professor Emeritus Annie Pardo, one of the leading experts on the pathophysiology of idiopathic pulmonary fibrosis. I guess the 🍎 does not fall far from the 🌳.

For over two decades, the scientific community has been puzzled by kidney cancer's resistance to rapalog drugs. James Brugarolas, M.D., Ph.D., reveals how #UTSW's recent study could pave the way for new therapeutic strategies to combat this issue. bit.ly/3VhLHsi #utswmed

Privileged to be hearing from scientist and #gupath colleague, Dr. Payal Kapur Payal Kapur at MSK Department of Pathology & Laboratory Medicine Grand Rounds focused of Morphology-Molecular correlates in #kidneycancer

#KCRS24 is a unique opportunity to engage with cutting edge science, foster collaborations, and share innovative ideas that will drive the #kidneycancer field forward. This session chaired by ROHIT MEHRA & Payal Kapur is poised to offer invaluable insights.

Fantastic opportunity to train with GU experts! #pathology #GUpath #pathresidents

Gratifying to see our findings shorturl.at/th7M6 James Brugarolas Payal Kapur validated in this large independent follow-up study shorturl.at/i5sQw -showing tumor thrombus grading can facilitate informed treatment decisions and disease progression risk in ccRCCs !! .

Super impressive work by Ryan Ink Factory creating real time visual notes to complement excellent science & learning at #KCRS24 - wonderful to see session 3 State of the Science #gupath brought to life! ROHIT MEHRA Michelle_Hirsch (Donovan) Payal Kapur Sabina Signoretti KidneyCAN

James Brugarolas KidneyCancerProgram Thank you for all the support and advice !!

Thank you. It was lovely to see you Neeraj.